The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation systems that use SureScan MRI leads, enabling a broader range of MRI scan parameters, ...
IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...
The FDA has approved expanded MRI labeling of Medtronic plc's (NYSE: MDT) InterStim II and InterStim Micro sacral neuromodulation (SNM) systems that use SureScan MRI leads. The updated MRI Guidelines ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback